This case illustrates different growth strategies in the pharmaceutical sector. Is management r&D a vital component of growth strategies, and the case demonstrates the relevance of using a holistic framework for R&D when enlarging the firm's company the of footprint.
The case serves the purpose of identifying the steps that are critical for the performance of these strategies, and comparing organic and inorganic growth strategies.
PUBLICATION DATE: August 21, 2015 PRODUCT #: IN1091-PDF-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
How to Get your Messages Retweeted
Julia Stasch (A)
Lean Manufacturing at FCI (A):The Global Challenge
The UK National Identity Card
A City’s Desert: No Apples in the Big Apple? (A)
Bayer CropScience in India (B): Value-Driven Strategy
“Captains of Lives” (B): The Transformation Journey of the Singapore Prison Service
Darcy Gallagher: Performance Coaching Discussion
Need, Creed, and Greed: Understanding Why Business Leaders Focus on Issues of Peace
Operationalizing Peace through Commerce: Toward an Empirical Approach
